Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Fluorouracil × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 39 Stomach Neoplasms 19 Pancreatic Neoplasms 16 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Adenocarcinoma Of Esophagus 10 Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 8 Cholangiocarcinoma 7 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma 4 Lung Neoplasms 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Anus Neoplasms 3 Advanced Solid Tumors 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡